148 related articles for article (PubMed ID: 37904832)
1. Risk Factors for Carbapenem-Resistant
Wu WQ; Zhang YQ; Xu J; Tang ZX; Li SJ; Wei XY; Li L; Wu HQ; Ma X; Liu JS; Wu DP; Wu XJ
Infect Drug Resist; 2023; 16():6821-6831. PubMed ID: 37904832
[TBL] [Abstract][Full Text] [Related]
2. Active Screening of Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae for Subsequent Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplantation.
Cao W; Zhang J; Bian Z; Li L; Zhang S; Qin Y; Wan D; Jiang Z; Zhang R
Infect Drug Resist; 2022; 15():5993-6006. PubMed ID: 36262593
[TBL] [Abstract][Full Text] [Related]
3. A clinical predictive model for pre-transplantation
Zhang Y-Q; Wu W-Q; Xu J; Tang Z-X; Li S-J; Li L; Wu H-Q; Ma X; Liu J-S; Wu D-P; Wu X-J
Microbiol Spectr; 2024 Feb; 12(2):e0203923. PubMed ID: 38189331
[TBL] [Abstract][Full Text] [Related]
4. Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
Su F; Luo Y; Yu J; Shi J; Zhao Y; Yan M; Huang H; Tan Y
Eur J Med Res; 2021 Apr; 26(1):37. PubMed ID: 33910622
[TBL] [Abstract][Full Text] [Related]
5. Different screening frequencies of carbapenem-resistant Enterobacteriaceae in patients undergoing hematopoietic stem cell transplantation: which one is better?
Yang TT; Luo XP; Yang Q; Chen HC; Luo Y; Zhao YM; Ye YS; Lai XY; Yu J; Tan YM; Wei GQ; Huang H; Shi JM
Antimicrob Resist Infect Control; 2020 Mar; 9(1):49. PubMed ID: 32183898
[TBL] [Abstract][Full Text] [Related]
6. Construction of a Risk Prediction Model for Subsequent Bloodstream Infection in Intestinal Carriers of Carbapenem-Resistant Enterobacteriaceae: A Retrospective Study in Hematology Department and Intensive Care Unit.
Wang Y; Lin Q; Chen Z; Hou H; Shen N; Wang Z; Wang F; Sun Z
Infect Drug Resist; 2021; 14():815-824. PubMed ID: 33688216
[TBL] [Abstract][Full Text] [Related]
7. Relationship of Oropharyngeal Colonization Microorganisms to Clinical Outcomes within 100 Days after Allogeneic Hematopoietic Stem Cell Transplantation.
Ge J; Wei X; Gu Y; Xie Y; Li H; Zhou S; Liu C; Li S; Wu W; Xu J; Ma X; Tang Z; He J; Wu D; Wu X; Liu J
Transplant Cell Ther; 2022 Aug; 28(8):496.e1-496.e7. PubMed ID: 35589057
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Modifying Empirical Antibiotic Therapy Based on Intestinal Colonization Status on Clinical Outcomes of Febrile Neutropenic Patients.
Alrstom A; Alsuliman T; Daher N; Abouharb R
Infect Chemother; 2021 Mar; 53(1):63-74. PubMed ID: 33538132
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics of carbapenem-resistant
Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
[No Abstract] [Full Text] [Related]
10. Incidence, etiology, risk factors, and outcomes of pre-engraftment bloodstream infections after first and second allogeneic hematopoietic cell transplantation.
Akhmedov M; Klyasova G; Kuzmina L; Fedorova A; Vasilyeva V; Drokov M; Parovichnikova E
Transpl Infect Dis; 2022 Jun; 24(3):e13842. PubMed ID: 35501664
[TBL] [Abstract][Full Text] [Related]
11. Investigation and Analysis of the Colonization and Prevalence of Carbapenem-Resistant
Sun Y; Yu L; Gao W; Cai J; Jiang W; Lu W; Liu Y; Zheng H
Infect Drug Resist; 2021; 14():1957-1966. PubMed ID: 34079305
[TBL] [Abstract][Full Text] [Related]
12. [Second allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and donor changes in relapsed hematological malignancies after the first allogeneic transplant].
Zhao YQ; Song YZ; Li ZH; Yang F; Xu T; Li FF; Yang DF; Wu T
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):465-471. PubMed ID: 37550201
[No Abstract] [Full Text] [Related]
13. Pre-transplant CRP-albumin ratio as a biomarker in patients receiving haploidentical allogeneic hematopoietic transplantation: Developing a novel DRCI-based nomogram.
Wang K; Jian X; Xu Z; Wang H
Front Immunol; 2023; 14():1128982. PubMed ID: 36875097
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Li T; Luo C; Zhang J; Wei L; Sun W; Xie Q; Liu Y; Zhao Y; Xu S; Wang L
Stem Cell Res Ther; 2021 Apr; 12(1):246. PubMed ID: 33879242
[TBL] [Abstract][Full Text] [Related]
15. Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study.
Giannella M; Freire M; Rinaldi M; Abdala E; Rubin A; Mularoni A; Gruttadauria S; Grossi P; Shbaklo N; Tandoi F; Ferrarese A; Burra P; Fernandes R; Aranha Camargo LF; Asensio A; Alagna L; Bandera A; Simkins J; Abbo L; Halpern M; Santana Girao E; Valerio M; Muñoz P; Fernandez Yunquera A; Statlender L; Yahav D; Franceschini E; Graziano E; Morelli MC; Cescon M; Viale P; Lewis R;
Clin Infect Dis; 2021 Aug; 73(4):e955-e966. PubMed ID: 33564840
[TBL] [Abstract][Full Text] [Related]
16. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey.
Girmenia C; Bertaina A; Piciocchi A; Perruccio K; Algarotti A; Busca A; Cattaneo C; Raiola AM; Guidi S; Iori AP; Candoni A; Irrera G; Milone G; Marcacci G; Scimè R; Musso M; Cudillo L; Sica S; Castagna L; Corradini P; Marchesi F; Pastore D; Alessandrino EP; Annaloro C; Ciceri F; Santarone S; Nassi L; Farina C; Viscoli C; Rossolini GM; Bonifazi F; Rambaldi A;
Clin Infect Dis; 2017 Nov; 65(11):1884-1896. PubMed ID: 29020286
[TBL] [Abstract][Full Text] [Related]
17. Carbapenem-resistant
Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
Front Public Health; 2022; 10():983174. PubMed ID: 36091556
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
19. Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation.
Forcina A; Lorentino F; Marasco V; Oltolini C; Marcatti M; Greco R; Lupo-Stanghellini MT; Carrabba M; Bernardi M; Peccatori J; Corti C; Ciceri F
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1476-1482. PubMed ID: 29501780
[TBL] [Abstract][Full Text] [Related]
20. A Prognostic Model Based on Clinical Biomarkers for Heart Failure in Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation.
Zhang AB; Wang CC; Zhao P; Tong KT; He Y; Zhu XL; Fu HX; Wang FR; Mo XD; Wang Y; Zhao XY; Zhang YY; Han W; Chen H; Chen Y; Yan CH; Wang JZ; Han TT; Sun YQ; Chen YH; Chang YJ; Xu LP; Liu KY; Huang XJ; Zhang XH
Transplant Cell Ther; 2023 Apr; 29(4):240.e1-240.e10. PubMed ID: 36634739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
